Heart lapaau - huaale 'Riboksin'

Kaʻeleu 'Oponopono o ka lāʻau mea inosine. Mākou e nānā i ka lāʻau mea i loaʻa i loko o na papa. Kēlā me kēia papa he 0,2 g. Oʻeleu 'Oponopono. Like kākoʻo waiwai hou i ka ka penaʻana hui, o ka kalipuna stearate, a me kaʻuala pia.

Papa "Riboxinum" - ua ka antihypoxic a me Anati-arrhythmic hana lāʻau anabolic hope paha. E like me ka precursor o ATP (adenosine triphosphate), he lāʻau 'ole i loko o monakō koko pūnao. Ma hypoxic rula, a me ka wāʻaʻole hoʻi he laau no ATP "Riboxinum" produces ka ho'ā 'ia' ana ma luna o ka pūnao o pyruvicʻakika, hiki kaulike i ka maʻamau kaʻina hana o ka'aʻaʻa ka hanu. No hoi, o ka lāʻau i ka maikaʻi ia ma luna o ka ho'ā hope o xanthine dehydrogenase.

He aha hou aʻe hai mai ai e pili ana i na ai '' Riboksin "kauoha no ka hoʻohana? O na papa io o ka lāʻau paipai 'ia ka pūnao i loko o ka myocardium. Kēia maoli ka halepaahao ikehu koena, he mea stimulation o ka nucleotide hoʻololi kemikala, maoli i ka ha awina o kekahi mau nā'ūhū. Papa "Riboxinum" ae alakaʻi i loko o ka myocardium ana, ka hoʻopukaʻana i kona contractile haʻawina, he piha hoʻomaha o cardiac Muscle ma diastole, ahu iho.

O ke kumu ho i ka hiki ana i ka lāʻau, e hoopaa i kalipuna Ion e komo na keena e inu nei. Papa "Riboxinum"ʻeleu paipai'aʻaʻa e noho. Ma 'ana, i ka hopena o ka lāʻau ua kuhikuhi' ana i ka myocardium a me mucous membranes o ka digestive'āpana.

E pili ana i ka hoʻohana 'ana i ka lāʻau "Riboksin" (papa), ke aʻo hoʻomōakaaka ka hilo, e kuhikuhi ana i ka lapaau ana o na kēia mau pathologies:

• Ischemic naau maʻi (IHD), postinfarction kulana angina. Ma kēia hihia, ua hoʻohana 'ia ka lāʻau i loko o ka iapaau ana.
• Cardiac glycoside intoxication.
• Cardiomyopathy o nā kêia kanaka.
• Myocarditis.
• Heart pāpana ka haunaele.

I eiiieaena hoomakaukau hana likeʻole naau mā, coronary atherosclerosis, myocarditis a me nā naʻau maʻi. Eia kekahi, o ka medicament "Riboxinum" (papa) o ka mea i hoonui ae i ka pilikia makapō kuleana pili i. Mau waiwai he hoʻonui i ka makaukau ana o kona hoʻohana i loko o ka maʻi i glaucoma otkrytouglovaya.

Pili "Riboksin" papa like penei: he kela la i keia mahele lāʻau o ka manawa i oleloia ai i loko o ka mua a me na keiki makua e hoomanawanui i ka 0.6-2.4 nā huna. Ka mua nā lā o ka lapaau ua lawe ekolu eha paha manawa i ka lā hoʻokahi no ka papa. Mai ke kolu o ka lā o ka noi komo 'ana ina tolerated lāʻau, ua mahuahua ka laʻau heluna i 1,2 - 1.4 nā huna no ka lā. Duration o ka Inc mea mai 28 lā a hiki i na malama ekolu. i ia nā papa ma mua o ka meaʻai.

IeAUPIIe, IAa IO keia k ua pono tolerated. Kanaka intolerance ke hoike mai ai ia ia iho ma ka oi o ka paipai laʻau heluna. Ua Ua olelo ia ma ka congestion, maneo ikeia. Ma ka hanana o ia mau hanana ua hōʻoki aku ka lapaʻauʻia. Nō hoʻi, pohihihi keia hihia i ua hoʻomaopopo i ka wa a ka iapaau ana o ka lāʻau i loko o ke koko pae mahuahua o ka urea i kekahi kākaʻikahi malama worsening o gout ma hope o hooloihi ae i lapaʻau me keia Agena.

Contraindications i ka hoʻohana 'i loaʻa ma luna o pathology. Oia, gout, a me pono me hypersensitivity i kaʻeleu waiwai. Eia hou, i ka lāʻau ua contraindicated ma ka hyperuricemia, kaupalena ke komo i loko o nā mea maʻi me kaʻaʻa puʻuwai insufficiency.

Like no ka polokalamu Hoʻopuka hou, laila, ma kaʻaʻa puʻuwai ole i loko o ka hoomanawanui e loaa ana i ka lāʻau "Riboksin" Ua nānā 'ia e kekahi kahuna lapaau hilinai ana ma ka oiaio i ka pono, ua hoaponoia. ua i lawe mai i ke kōkua o kēia k pilikia cardiac kāna hana e hooponopono.

Inā ka lāʻau "Riboxinum" (papa) hoʻohana i ka huipūʻana me ka β-adrenergic blockers, kona hookoia ua i hoemiia. I ka hui 'ana o cardiac glycosides kōkua pale hoikeana o arrhythmias, a mahuahua inotropic hana.